Cargando…
B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia
Spurred by better understanding of disease biology, improvements in molecular diagnostics, and the development of targeted therapies, the treatment of acute myeloid leukemia (AML) has undergone significant evolution in recent years. Arguably, the most exciting shift has come from the success of trea...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443828/ https://www.ncbi.nlm.nih.gov/pubmed/32879842 http://dx.doi.org/10.5306/wjco.v11.i8.528 |